News
-Alamar Biosciences amplía el panel NULISAseq™ de enfermedades del SNC 120 con innovadores ensayos de pTau de origen cerebral basados en sangre Este panel, pionero en su tipo, incluye ensayos ...
FREMONT, Calif., June 10, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, the Alzheimer's Disease Data Initiative and ...
FREMONT, Calif., Feb. 24, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the release of the ...
FREMONT, Calif., May 28, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease is proud to announce a strategic collaboration ...
First-of-its-kind panel includes brain-derived pTau217, pTau181, pTau231, and total tau assays to advance neurodegenerative disease research FREMONT, Calif., May 15, 2025 /PRNewswire/ -- Alamar ...
FREMONT, Calif., May 28, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease is proud to announce a strategic collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
